Haemonetics Financial Overview
Haemonetics's market cap is currently $3.76B. The company's EPS TTM is $1.27; its P/E ratio is 23.42; Haemonetics is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is $1.25. See an overview of income statement, balance sheet, and cash flow financials.
